Orient Pharma Co., Ltd. (TPEX: 4166)

Orient Pharma Revenue

Orient Pharma had revenue of 602.98M TWD in the half year ending June 30, 2024, with 104.34% growth. This brings the company's revenue in the last twelve months to 1.07B, up 65.47% year-over-year. In the year 2023, Orient Pharma had annual revenue of 889.91M with 73.86% growth.

• Revenue (ttm): 1.07B
• Revenue Growth: +65.47%
• P/S Ratio: 7.74
• Revenue / Employee: 6.16M
• Employees: 173
• Market Cap: 8.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	889.91M	378.05M	73.86%
Dec 31, 2022	511.86M	48.52M	10.47%
Dec 31, 2021	463.34M	51.33M	12.46%
Dec 31, 2020	412.01M	58.47M	16.54%
Dec 31, 2019	353.54M	84.00M	31.16%